Fed. Circ. Upholds Abbott's $16M Win Over Tarka Patent
The Federal Circuit on Monday upheld a $16 million jury verdict against generic-drug maker Glenmark Pharmaceuticals Ltd. for allegedly infringing a patent licensed exclusively to Abbott Laboratories for the blood pressure...To view the full article, register now.
Already a subscriber? Click here to view full article